• If you are wondering whether Teradyne’s current price really reflects what you are getting for your money, you are not alone. This article is designed to answer exactly that question.
• Teradyne’s share price recently closed at US$305.58, after a 7 day return of 8.2% decline, a 30 day return of 8.0%, a year to date return of 47.2% and a 1 year return of 191.0%. This naturally raises questions about how much of this is already baked into the valuation and how much risk you are taking on at these levels.
• Recent coverage has focused on Teradyne’s role in the semiconductor testing space and how investors are reacting to that context, which helps explain some of the strong returns over the past year. This article was triggered to provide ongoing coverage so you can see how that story ties back to what the stock might be worth today.
• Right now, Teradyne has a valuation score of 0 out of 6. Next we will walk through the standard valuation methods that lead to that result, before finishing with a way to look at valuation that goes beyond a single score.

Teradyne scores just 0/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Teradyne Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a company could be worth by projecting its future cash flows and discounting them back to today’s dollars. It is essentially asking what all those future cash flows are worth right now.

For Teradyne, the latest twelve month Free Cash Flow is about US$460.8 million. Analysts have provided explicit forecasts out to 2030, after which Simply Wall St extrapolates further. Those projections step up over time, with forecast Free Cash Flow of US$2.05 billion in 2030 and additional modeled years out to 2035.

Putting those cash flows through a 2 Stage Free Cash Flow to Equity model gives an estimated intrinsic value of about US$172.33 per share. Compared with the recent share price of US$305.58, the model output implies the shares are about 77.3% above that DCF estimate. This suggests that, according to this particular cash flow based valuation, Teradyne is trading at a higher level than the model’s estimate of intrinsic value.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Teradyne may be overvalued by 77.3%. Discover 47 high quality undervalued stocks or create your own screener to find better value opportunities.

Approach 2: Teradyne Price vs Earnings

For a profitable company like Teradyne, the P/E ratio is a straightforward way to relate what you pay per share to the earnings that support that price. It gives you a quick sense of how many dollars investors are currently willing to pay for each dollar of earnings.

What counts as a “normal” P/E depends heavily on expectations for future growth and how much risk investors see in the business. Higher expected growth and lower perceived risk tend to justify a higher multiple, while slower growth or higher uncertainty usually point to a lower one.

Teradyne currently trades at a P/E of 86.35x. That sits above the Semiconductor industry average of 42.05x and also above the peer group average of 52.27x. Simply Wall St’s Fair Ratio metric for Teradyne is 48.00x. This Fair Ratio is a proprietary estimate of what P/E might make sense given Teradyne’s earnings growth profile, profit margins, industry, market cap and risk factors. It aims to be more tailored than a simple comparison with peers or the broad industry because it blends those company specific drivers into a single reference point.

Compared with this Fair Ratio of 48.00x, Teradyne’s actual P/E of 86.35x looks elevated.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Teradyne Narrative

Earlier we mentioned that there is an even better way to think about valuation. On Simply Wall St that comes through Narratives, where you and other investors set out a clear story for Teradyne, link that story to explicit forecasts for revenue, earnings and margins, and arrive at a Fair Value that you can compare with the current price on the Community page used by millions of investors.

Each Narrative connects what you believe about Teradyne to numbers, then to a Fair Value. It updates automatically when fresh information such as earnings or news arrives, so your view is always grounded in the latest data rather than a one off snapshot.

For example, one Teradyne Narrative currently points to a Fair Value of about US$397.65 per share, while another is closer to US$141.40, and a third sits around US$192.38. This shows how investors looking at the same company can arrive at very different Fair Values based on their assumptions and gives you a clear, structured way to decide whether the current price looks high, low, or roughly in line with your own view.

For Teradyne, however, we will make it really easy for you with previews of two leading Teradyne Narratives:

Fair value in this bullish narrative: US$397.65 per share

Implied discount vs recent price: about 23.4% below that fair value estimate

Revenue growth assumption: 29.51% a year

• Supports the view that Teradyne could benefit from increasing AI chip complexity, high bandwidth memory testing and connected devices, with test and robotics demand feeding into revenue and margin expansion.
• Assumes strong balance sheet support, ongoing cash generation and a sizeable buyback program help fund investment and improve earnings quality while returning cash to shareholders.
• Flags key risks around heavy exposure to cyclical capex, geopolitical and trade policy uncertainty, pressure on the Robotics division and competition that could weigh on margins if industry conditions change.

Fair value in this more cautious narrative: US$192.38 per share

Implied premium vs recent price: about 58.9% above that fair value estimate

Revenue growth assumption: 17.01% a year

• Views AI, robotics and semiconductor automation as potential growth drivers, helped by the Quantifi Photonics acquisition and a sizeable buyback, but with a more moderate outlook for earnings and margins.
• Builds in analyst expectations for mid-teens annual revenue growth, higher profit margins over time and a P/E multiple that is lower than today, resulting in a fair value close to prior consensus targets.
• Highlights risks from tariffs, trade policy, softer robotics revenue and swings in product mix, all of which could affect demand, gross margins and the reliability of earnings forecasts.

Do you think there's more to the story for Teradyne? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.